TRANSFIGURE
DEAD

Serial Number

77688851

Owner

Transfigure Investments LLC

Attorney

Leon G. Rendeiro Jr.

First Use Date

Aug 22, 2005

Filing Date

Mar 11, 2009

Add to watchlist:

No watchlists yet
View on USPTO

TRANSFIGURE Trademark

Serial Number: 77688851 • Registration: 3686000

TRANSFIGURE is a trademark filed by Transfigure Investments LLC on March 11, 2009. The trademark is classified under Class 36 (Insurance & Financial), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Transfigure Investments LLC (3 trademarks)

1754 Concord Hill Dr.
Anchorage, AK 99515

Entity Type: 16

Trademark Details

Filing Date

March 11, 2009

Registration Date

September 22, 2009

First Use Anywhere

August 22, 2005

First Use in Commerce

August 22, 2005

Published for Opposition

July 7, 2009

Cancellation Date

August 13, 2020

Goods & Services

Evaluation of the credit worthiness of companies and private individuals; Leveraged buy outs and investments in financially distressed or underperforming companies; Trust services, namely, investment and trust company services; Venture capital funding services to emerging and start-up companies; Venture capital services, namely, providing financing to emerging and start-up companies

Administrative processing of purchase orders within the framework of services provided by mail-order companies; An interactive web site for users to review and rate internet content, people, companies, products and/or services utilizing a software application to award points whereby web site users are eligible to exchange points earned for promotional items consisting of coupons, rebates, discounts or special offerings on goods and/or service provided by web site sponsors; Arranging the transport of vehicles of insured parties on behalf of their insurance companies for resolution of insurance claims; Audit support services, namely, review and analysis of a company's sales, as well as the preparation, organization and presentation of the documents and data requested by a government body, and advice on government audit processes, policies and strategy; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business information services, namely, gathering and reporting information regarding e-mail addresses of others that are made available to other companies for commercial purposes; Business management assistance for industrial or commercial companies; Business management consulting with relation to strategy, financing, marketing, production, personnel and sale matters for companies involved with thin film and nano technologies and plasma processes; Business management services, namely, purchasing of and selling of companies for others; Company management, including consultancy in demographic matters; Consultation services in the field of company, business sector and industry data and research; Creation of marketing tools designed to increase a client company's knowledge of customer needs, and its competitors' products and services, pricing, advertising strategy and sales strategy; Economic consulting and information for the industrial and commercial sectors for planning, organizing, monitoring and carrying out unique and complex projects in different sectors of one or several companies; Fund raising for others for the purpose of purchasing companies; Information and expert opinions relating to companies and business; Lobbying services, namely, promoting the interests of international, real estate and nonprofit companies in the fields of politics, legislation, and regulation; Management of an airline company; Marketing and branding services, namely, performing consumer insight and brand strategy of company logos; Processing energy utility customer rebates for utility companies; Providing a live forum for companies to showcase, display, demonstrate and promote new and innovative ideas, products and services in the convention/meeting management arena; Providing an interactive web site for persons to register complaints against companies and/or services of all types; Providing technical consulting services and information management services, namely, clinical data and regulatory submission management to medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 9, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 9, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 9, 2022 REAP
PETITION TO DIRECTOR DENIED
May 3, 2021 PCDE
ASSIGNED TO PETITION STAFF
Mar 9, 2021 APET
TEAS PETITION TO DIRECTOR RECEIVED
Sep 22, 2020 TPDR
NOTICE OF CANCELLATION SEC. 8 EMAILED
Aug 14, 2020 NCS8
CANCELLED SEC. 8 (10-YR)
Aug 13, 2020 C8.T
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Feb 12, 2020 PR89
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Feb 4, 2020 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Sep 4, 2019 PR89
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 29, 2019 APRE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 23, 2019 TCCA
TEAS SECTION 8 & 9 RECEIVED
Aug 23, 2019 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sep 22, 2018 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Oct 1, 2014 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Oct 1, 2014 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 29, 2014 APRE
TEAS SECTION 8 RECEIVED
Sep 22, 2014 ES8R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 22, 2014 TCCA
REGISTERED-PRINCIPAL REGISTER
Sep 22, 2009 R.PR
PUBLISHED FOR OPPOSITION
Jul 7, 2009 PUBO
NOTICE OF PUBLICATION
Jun 17, 2009 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 4, 2009 PREV
ASSIGNED TO LIE
Jun 4, 2009 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 2, 2009 CNSA
ASSIGNED TO EXAMINER
Jun 2, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2009 NWOS
NEW APPLICATION ENTERED
Mar 14, 2009 NWAP